Posted 10/19/2017 1:42 AM (GMT 0)
I have not heard of the idea that Xtandi works better on bone mets vs. lymph node or other soft tissue mets. I wonder, "How would it know the difference?"
In my case (see below), I had a rising "resistant" PSA, and about 10 mixed, active "hot spots" as confirmed by a Ga-68 PSMA PET scan, involving both bones and lymph nodes (lungs and liver are clear), when I started on Xtandi at the end of November 2016, with a PSA of 95. After 11 months, my PSA is down to 1.4. A NM Bone Scan and regular CT Scan in the Spring of 2017 were essentially "stable", and unchanged from a year earlier.
(I was diagnosed in 2013, before the results of the CHAARTED, STAMPEDE, and LATITUDE Clinical Trials started making their way into clinical practice. Were I similarly diagnosed today, I would have considered Chemo earlier, rather than later.)
Charles